CompletedNCT03497013
Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive Dyskinesia
Device studyAges 18–70China
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- Suzhou, ChinaSee all locations and recruitment
- Activities
- Device procedures described in the protocol · Sham comparator
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateStarted: July 31, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 64
- Sponsor
- Suzhou Psychiatric Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- China
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT03497013
- Official title
Show the full official title
Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive dyskinesia_a Randomized, Double-blind, Sham-controlled Trial
Recruitment & locations
CompletedSuzhou
Questions about this study
Who is behind this study?
The study sponsor is Suzhou Psychiatric Hospital, a hospital or academic medical center.
Who was this study for?
Listed age limits: 18 years to 70 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meRelated studies
Developing Dual-channel Transcranial Alternating Current Stimulations Targeting Negative Symptoms in Schizophrenia
Effect of Intermittent Theta Burst Stimulation (iTBS) for Alleviating Symptoms of Schizophrenia Patients